Breadcrumb
- Home
- Infection In Pulmonary Vascular Disease (iPVD) Consortium
- About The IPVD Consortium
About the iPVD Consortium
The risk of subjects developing PH is four to six times higher in developing countries compared to developed regions of the world probably because of infectious diseases. Many infections contribute to PH including schistosomiasis and other Helminthic diseases: viral infections (such as HIV), fungal infections (like Paracoccidioides brasiliensis (paracoccidioidomycosis)), bacterial infections (such as Bordetella pertussis), and probably tuberculosis.
Despite the large prevalence of the infectious etiologies of PH, many knowledge gaps exist in understanding how the infectious agents lead to PVDs, ultimately resulting in a lack of adequate therapies and public education. To address these unmet needs, a group of scientists and physicians met in Canterbury in October 2018 to establish this Consortium (iPVD).
The iPVD Consortium represents a systematic and coherent effort to investigate the role of infection in PH.
Our Executive Committee
President, iPVD (2025-Current)
Associate Professor of Medicine
Universidade Federal de São Paulo, Brazil
Assistant Professor
Texas Tech University Health Sciences Center, USA
Professor of Cardiopulmonary Sciences
University of Kent, United Kingdom
Assistant Professor
University of Illinois at Chicago, USA
(Past iPVD Consortium President, 2023-2024)
Professor of Medicine
University of Kansas Medical Center, USA
Assistant Professor of Medicine
University of California San Francisco, USA
Associate Professor of Medicine with Tenure
Stanford University Medical Center, USA
Professor of Medicine
Stellenbosch University, South Africa
- Sergey Avdeev, Sechenov Medical University, Moscow, Russia
- Andrew Bryant, University of Florida, Gainesville, USA
- Amaya Bustinduy, London School of Hygiene & Tropical Medicine, London, UK
- Eloara Campos, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
- Stephen Chan, University of Pittsburgh, Pittsburgh, USA
- Matthias Clauss, Indiana University School of Medicine, Indianapolis, USA
- Angel Cogolludo, Universidad Complutense de Madrid, Madrid, Spain
- Ricardo Correa, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil
- Ana Carolina Duarte, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
- Mostafa Elshazly, Cairo University, Cairo, Egypt
- Alexandre Fabro, FMRP/USP e UNIPEX/UNESP, Botucatu, Brazil
- Edgar Fernández-Malavé, Universidad Complutense de Madrid, Madrid, Spain
- Brian Graham, University of California San Francisco (UCSF), San Francisco, USA
- Stefan Hadzic, Justus-Liebig-Universität Gießen, Giessen, Germany
- Michael Hansen, J and J
- Ahmed Hassan, Cairo University, Cairo, Egypt
- Adeel Ahmed Iqbal, NHS, London, UK
- Camila Loureiro, Santa Casa da Bahia, Federal University of Bahia, Salvador, Brazil
- Gerald Maarman, Stellenbosch University, Cape Town, South Africa
- Harriet Mayanja-Kizza, Makerere University, Kampala, Uganda
- Sandra Medrano-Garcia, Center for Infection and Genomics of the Lung (CIGL), Justus-Liebig-Universität Gießen, Giessen, Germany
- Thais Menezes, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
- Claudia Mickael, University of Colorado, Aurora, USA
- Ana Mocumbi, Universidade Eduardo Mondlane, Maputo, Mozambique
- Daniel Morales-Cano, Department of Pharmacology and Toxicology, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain
- Fernanda Oliveira, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
- Francisco Perez-Vizcaino, Universidad Complutense de Madrid, Madrid, Spain
- Nicola Petrosillo, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
- Angela Pontes Bandeira de Oliveira, PROCAPE – Pernambuco’s University, Recife – Pernambuco, Brazil
- Doris Yasinti Sakala, Stellenbosch University, Cape Town, South Africa
- Lilian Sanna, J and J
- Juliana Santos, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
- Yusuf Ziya Şener, Yavuzeli State Hospital, Turkey
- Friedrich Thienemann, University of Cape Town and University of Zurich, Cape Town/Zurich, South Africa
- Olga Tura-Ceide, Institut d’Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain
- Emma Veale, University of Kent, Medway Maritime, UK
- Cheng-Yu Wu, Justus-Liebig-Universität Gießen, Giessen, Germany
If you are interested in joining the iPVD Consortium please fill in the form below.
iPVD Member request form
Want to be part of something special?
All PVRI members are welcome to join an IDDI Workstream or a Task Force.